Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 27;13(3):530-534.
doi: 10.21037/tp-23-521. Epub 2024 Mar 6.

Blinatumomab improves outcomes for pediatric patients with low-risk B-cell acute lymphoblastic leukemia in first marrow relapse

Lindsey Murphy  1 , Ibrahim Aldoss  2
Affiliations
Editorial

Blinatumomab improves outcomes for pediatric patients with low-risk B-cell acute lymphoblastic leukemia in first marrow relapse

Lindsey Murphy et al. Transl Pediatr. .
No abstract available

Keywords: Acute lymphoblastic leukemia (ALL); blinatumomab; first relapse.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-521/coif). I.A. reports serving on Advisory Boards for Amgen and KiTE Pharm. I.A. served as a consultant for Amgen, and received consulting fees and payment from them. The other author has no conflicts of interest to declare.

Comment on

References

    1. Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med 2015;373:1541-52. 10.1056/NEJMra1400972 - DOI - PubMed
    1. Hunger SP, Raetz EA. How I treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood 2020;136:1803-12. 10.1182/blood.2019004043 - DOI - PubMed
    1. Pui CH, Yang JJ, Hunger SP, et al. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J Clin Oncol 2015;33:2938-48. 10.1200/JCO.2014.59.1636 - DOI - PMC - PubMed
    1. Nguyen K, Devidas M, Cheng SC, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia 2008;22:2142-50. 10.1038/leu.2008.251 - DOI - PMC - PubMed
    1. Coustan-Smith E, Gajjar A, Hijiya N, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia 2004;18:499-504. 10.1038/sj.leu.2403283 - DOI - PubMed